Pharmacross announces the appointment of Rosario Di Serio as Commercial Manager. In his new role, he will oversee the company’s commercial operations, including contract negotiations, approval processes, and risk management, supporting Pharmacross’ business development and growth.

Pharmacross introduces jGARD® paste, a highly palatable complementary feed specially formulated for small dogs with osteoarthritis. Rich in omega-3 fatty acids, it supports joint function and helps manage inflammation and reduced mobility. Available in a convenient 30 ml calibrated syringe, it ensures easy and accurate daily administration.

Pharmacross officially launched its new website on December 7, 2018, offering visitors an improved experience and easier access to information about the company, its products, and pet health. Featuring a modern design, social media integration, and regularly updated content, the website marked an important step in strengthening communication with customers and veterinary professionals.

Pharmacross held a successful partner meeting in Riga with its distributors Sia Universitates Vetfonds (Latvia) and UAB Vetslénis (Lithuania). The event focused on product training, sharing new ideas, and strengthening collaboration, celebrating the achievements of 2018 and laying the foundation for a successful 2019.

The ESVNU Abstract Award recognizes outstanding research in veterinary nephrology and urology, encouraging scientific development among young academics. The first prize was awarded to H.J. Sargent and colleagues from the Royal Veterinary College, London, for their research on feline chronic kidney disease, while the second prize went to T. Johnstone and D. Bulach from the University of Melbourne for their study on urinary tract infections in dogs.

Pharmacross distributors in Latvia and Lithuania organized seven scientific seminars on Chronic Kidney Disease over five days, covering nearly 1,200 km. Led by Dr. Andrea Zatelli, Pharmacross CSO, the initiative received excellent feedback, reinforcing the company’s commitment to veterinary education and scientific excellence.

Pharmacross is committed to complete transparency in product composition and ingredient sourcing. Through its “100% Transparent” campaign, the company provides detailed technical information on its products, including the purity and quantity of active ingredients, reinforcing its dedication to quality, trust, and the well-being of pets.

Dr. Xavier Roura from the Universitat Autònoma de Barcelona led a well-attended veterinary seminar at Xara Lodge in Rabat, Malta. The event focused on the latest treatments and preventive approaches for feline diseases, providing local veterinarians with valuable insights into feline health and clinical care.

Pharmacross, in collaboration with Idexx Laboratories, organized a veterinary seminar in Malta featuring Dr. Xavier Roura from the Universitat Autònoma de Barcelona. The event brought together veterinarians from Malta and Gozo to explore the latest approaches to feline diseases, including FeLV, FIV, and FIP, reinforcing both companies’ commitment to scientific education and veterinary excellence.

Pharmacross, in partnership with Hill’s and Merial, organized a nationwide speaker tour across Italy focused on chronic kidney disease in dogs and cats. The initiative attracted over 400 veterinarians, providing valuable continuing education on the management of renal disease in companion animals.